Cardiovascular disease and cumulative incidence of cognitive impairment in the Health and Retirement Study

Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort. Methods We employed Health and Ret...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:BMC geriatrics Ročník 21; číslo 1; s. 274 - 9
Hlavní autori: Covello, Allyson L., Horwitz, Leora I., Singhal, Shreya, Blaum, Caroline S., Li, Yi, Dodson, John A.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London BioMed Central 26.04.2021
BioMed Central Ltd
Springer Nature B.V
BMC
Predmet:
ISSN:1471-2318, 1471-2318
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort. Methods We employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age ≥ 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score  <  11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death. Results Mean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference − 0.9, 95% confidence interval − 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model. Conclusions Overall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline.
AbstractList Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort. Methods We employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age ≥ 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score < 11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death. Results Mean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference − 0.9, 95% confidence interval − 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model. Conclusions Overall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline.
We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort. We employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age ≥ 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score < 11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death. Mean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference - 0.9, 95% confidence interval - 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model. Overall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline.
Abstract Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort. Methods We employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age ≥ 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score < 11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death. Results Mean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference − 0.9, 95% confidence interval − 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model. Conclusions Overall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline.
Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort. Methods We employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age [greater than or equai to] 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score < 11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death. Results Mean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference - 0.9, 95% confidence interval - 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model. Conclusions Overall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline. Keywords: Cardiovascular disease, Cognition, Geriatric cardiology
Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort. Methods We employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age ≥ 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score  <  11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death. Results Mean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference − 0.9, 95% confidence interval − 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model. Conclusions Overall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline.
We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort.BACKGROUNDWe sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort.We employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age ≥ 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score < 11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death.METHODSWe employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age ≥ 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score < 11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death.Mean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference - 0.9, 95% confidence interval - 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model.RESULTSMean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference - 0.9, 95% confidence interval - 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model.Overall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline.CONCLUSIONSOverall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline.
We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI) compared to people without CVD, as suggested by prior studies, using a large longitudinal cohort. We employed Health and Retirement Study (HRS) data collected biennially from 1998 to 2014 in 1305 U.S. adults age [greater than or equai to] 65 newly diagnosed with CVD vs. 2610 age- and gender-matched controls. Diagnosis of CVD was adjudicated with an established HRS methodology and included self-reported coronary heart disease, angina, heart failure, myocardial infarction, or other heart conditions. CI was defined as a score < 11 on the 27-point modified Telephone Interview for Cognitive Status. We examined incidence of CI over an 8-year period using a cumulative incidence function accounting for the competing risk of death. Mean age at study entry was 73 years, 55% were female, and 13% were non-white. Cognitive impairment developed in 1029 participants over 8 years. The probability of death over the study period was greater in the CVD group (19.8% vs. 13.8%, absolute difference 6.0, 95% confidence interval 2.2 to 9.7%). The cumulative incidence analysis, which adjusted for the competing risk of death, showed no significant difference in likelihood of cognitive impairment between the CVD and control groups (29.7% vs. 30.6%, absolute difference - 0.9, 95% confidence interval - 5.6 to 3.7%). This finding did not change after adjusting for relevant demographic and clinical characteristics using a proportional subdistribution hazard regression model. Overall, we found no increased risk of subsequent CI among participants with CVD (compared with no CVD), despite previous studies indicating that incident CVD accelerates cognitive decline.
ArticleNumber 274
Audience Academic
Author Horwitz, Leora I.
Singhal, Shreya
Blaum, Caroline S.
Covello, Allyson L.
Li, Yi
Dodson, John A.
Author_xml – sequence: 1
  givenname: Allyson L.
  surname: Covello
  fullname: Covello, Allyson L.
  email: allyson.covello@nyulangone.org
  organization: New York University Grossman School of Medicine
– sequence: 2
  givenname: Leora I.
  surname: Horwitz
  fullname: Horwitz, Leora I.
  organization: Division of Healthcare Delivery Science, Department of Population Health, NYU Grossman School of Medicine
– sequence: 3
  givenname: Shreya
  surname: Singhal
  fullname: Singhal, Shreya
  organization: NYU Steinhardt School of Culture, Education, and Human Development
– sequence: 4
  givenname: Caroline S.
  surname: Blaum
  fullname: Blaum, Caroline S.
  organization: National Committee for Quality Assurance
– sequence: 5
  givenname: Yi
  surname: Li
  fullname: Li, Yi
  organization: Division of Biostatistics, Department of Population Health, NYU Grossman School of Medicine
– sequence: 6
  givenname: John A.
  surname: Dodson
  fullname: Dodson, John A.
  organization: Division of Healthcare Delivery Science, Department of Population Health, NYU Grossman School of Medicine, Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33902466$$D View this record in MEDLINE/PubMed
BookMark eNp9kktr3DAUhU1JaR7tH-iiGLrpZlI9LFneFMLQJoFAoY-1kKWrGQ22NJXsgfz7yuMknQklGEvm6jtH3OtzXpz44KEo3mN0ibHgnxMmoq4XiODpbfL6qjjDVY0XhGJxcvB9WpyntEEI14LwN8UppQ0iFednxWaponFhp5IeOxVL4xKoBKXyptRjn2uD20HpvHYGvIYy2FKHlXdzud8qF3vwQybKYQ3lDahuWO_lP2BwEfaHP4fR3L8tXlvVJXj3sF8Uv799_bW8Wdx9v75dXt0tNEf1sKi5YJUR2BKjOQVLq6pFlAqmMbFMaY0qzJChnNi2biuRl5oAbWjbYMOxoBfF7exrgtrIbXS9ivcyKCf3hRBXUsXB6Q6k0aalzJJW8bZCrGkaZcCAVYgRS_Tk9WX22o5tD0bnZqLqjkyPT7xby1XYSYHqimGWDT49GMTwZ4Q0yN4lDV2nPIQxScKwaJr8Zyb04zN0E8bo86gyRYRoBOUH1ErlBpy3Id-rJ1N5xTmusGD1RF3-h8qPgd7pHCPrcv1I8OGw0acOH5OSATIDOoaUItgnBCM5xVHOcZQ5inIfR4mySDwTaTfkRIVpWK57WUpnacr3-BXEf9N4QfUXpnzzqA
CitedBy_id crossref_primary_10_1161_JAHA_123_033594
crossref_primary_10_3389_fpubh_2024_1385089
crossref_primary_10_1002_alz_13006
crossref_primary_10_1016_j_jamda_2023_08_022
crossref_primary_10_1080_15332985_2025_2542343
crossref_primary_10_3389_fnagi_2023_1257367
crossref_primary_10_1155_2022_8958099
crossref_primary_10_1177_02676591251350517
crossref_primary_10_1186_s12933_025_02575_1
crossref_primary_10_1016_j_jacc_2025_04_057
crossref_primary_10_1097_JCN_0000000000001255
Cites_doi 10.1001/jamaneurol.2015.2161
10.1093/workar/wax032
10.1161/STROKEAHA.107.501106
10.1016/j.jacc.2019.04.019
10.1093/ndt/gft355
10.1161/hs1101.098360
10.1016/j.amjmed.2012.05.029
10.1093/aje/kwj025
10.1038/nrneurol.2012.263
10.1080/01621459.1999.10474144
10.1136/heartjnl-2012-301682
10.1161/circheartfailure.117.004476
10.7326/0003-4819-158-5-201303050-00007
10.1371/journal.pone.0184244
10.1016/s0002-9149(98)00082-4
10.1002/gps.830
10.1016/j.cjca.2017.09.024
10.1111/j.1532-5415.2012.04097.x
10.1007/s12035-019-01655-0
10.1212/WNL.57.11.1945
10.1016/j.amjcard.2017.11.003
10.1159/000493142
10.1161/01.STR.22.2.195
10.1007/s11065-017-9359-z
10.1067/mhj.2000.106647
10.1093/eurheartj/ehx365
10.1093/geronb/gbr048
ContentType Journal Article
Copyright The Author(s) 2021
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7QP
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12877-021-02191-0
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
PubMed



MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Statistics
EISSN 1471-2318
EndPage 9
ExternalDocumentID oai_doaj_org_article_dcdb35f2ba6b405999adedefa052f2c8
PMC8074515
A661418575
33902466
10_1186_s12877_021_02191_0
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABUWG
ACGFO
ACGFS
ACHQT
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
AFFHD
CITATION
ALIPV
NPM
3V.
7QP
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c607t-76854d81f2dc63ef344b03385c12f5acc04150d362fb7b48b7b72e393b91d6183
IEDL.DBID BENPR
ISICitedReferencesCount 12
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000645595000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1471-2318
IngestDate Fri Oct 03 12:53:08 EDT 2025
Tue Nov 04 02:01:02 EST 2025
Fri Sep 05 06:54:24 EDT 2025
Tue Oct 07 05:15:36 EDT 2025
Tue Nov 11 09:59:56 EST 2025
Tue Nov 04 18:09:00 EST 2025
Thu Apr 03 06:58:07 EDT 2025
Tue Nov 18 22:35:12 EST 2025
Sat Nov 29 06:37:22 EST 2025
Sat Sep 06 07:29:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Geriatric cardiology
Cardiovascular disease
Cognition
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-76854d81f2dc63ef344b03385c12f5acc04150d362fb7b48b7b72e393b91d6183
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2528898365?pq-origsite=%requestingapplication%
PMID 33902466
PQID 2528898365
PQPubID 44817
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_dcdb35f2ba6b405999adedefa052f2c8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8074515
proquest_miscellaneous_2518990015
proquest_journals_2528898365
gale_infotracmisc_A661418575
gale_infotracacademiconefile_A661418575
pubmed_primary_33902466
crossref_primary_10_1186_s12877_021_02191_0
crossref_citationtrail_10_1186_s12877_021_02191_0
springer_journals_10_1186_s12877_021_02191_0
PublicationCentury 2000
PublicationDate 2021-04-26
PublicationDateYYYYMMDD 2021-04-26
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-26
  day: 26
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC geriatrics
PublicationTitleAbbrev BMC Geriatr
PublicationTitleAlternate BMC Geriatr
PublicationYear 2021
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References PC Austin (2191_CR33) 2017
RJ Fine (2191_CR29) 1999; 94
TR Gure (2191_CR5) 2012; 60
KM Langa (2191_CR27) 2018
F Bursi (2191_CR19) 2006; 163
2191_CR31
CA de Jager (2191_CR25) 2003; 18
2191_CR17
NR Grubb (2191_CR20) 2000; 140
C-C Liu (2191_CR34) 2013; 9
GG Fisher (2191_CR22) 2018; 4
M Lutski (2191_CR7) 2018; 121
H Petrovitch (2191_CR21) 1998; 81
BL Plassman (2191_CR24) 1994; 7
GG Fisher (2191_CR28) 2017
2191_CR1
EM Crimmins (2191_CR26) 2011; 66
RJ Gray (2191_CR32) 2019
N Gruhn (2191_CR9) 2001; 32
C Toledo (2191_CR13) 2019; 56
L Rivard (2191_CR14) 2017; 33
K Deckers (2191_CR3) 2017; 12
M Noordzij (2191_CR30) 2013; 28
PM Pullicino (2191_CR11) 2001; 57
W Xie (2191_CR18) 2019; 73
MA Ikram (2191_CR10) 2008; 39
CA Hammond (2191_CR16) 2018; 11
CT Cigolle (2191_CR23) 2018; 73
KB Stefanidis (2191_CR8) 2018; 28
JA Dodson (2191_CR35) 2013; 126
S Kalantarian (2191_CR6) 2013; 158
RF de Bruijn (2191_CR2) 2015; 72
R Schmidt (2191_CR15) 1991; 22
LH Eggermont (2191_CR4) 2012; 98
LS Redwine (2191_CR12) 2018; 25
References_xml – volume: 7
  start-page: 235
  year: 1994
  ident: 2191_CR24
  publication-title: Neuropsychiatry Neuropsychol Behav Neurol
– volume: 72
  start-page: 1288
  issue: 11
  year: 2015
  ident: 2191_CR2
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2015.2161
– volume-title: Langa-Weir classification of cognitive function (1995 onward)
  year: 2018
  ident: 2191_CR27
– volume: 4
  start-page: 1
  issue: 1
  year: 2018
  ident: 2191_CR22
  publication-title: Work Aging Retire
  doi: 10.1093/workar/wax032
– volume: 73
  start-page: 901
  year: 2018
  ident: 2191_CR23
  publication-title: J Gerontol B Psychol Sci Soc Sci.
– volume: 39
  start-page: 1421
  issue: 5
  year: 2008
  ident: 2191_CR10
  publication-title: Stroke.
  doi: 10.1161/STROKEAHA.107.501106
– ident: 2191_CR1
– volume: 73
  start-page: 3041
  issue: 24
  year: 2019
  ident: 2191_CR18
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2019.04.019
– volume: 28
  start-page: 2670
  issue: 11
  year: 2013
  ident: 2191_CR30
  publication-title: Nephrol Dial Transpl
  doi: 10.1093/ndt/gft355
– volume: 32
  start-page: 2530
  issue: 11
  year: 2001
  ident: 2191_CR9
  publication-title: Stroke.
  doi: 10.1161/hs1101.098360
– volume: 126
  start-page: 120
  issue: 2
  year: 2013
  ident: 2191_CR35
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2012.05.029
– volume: 163
  start-page: 135
  issue: 2
  year: 2006
  ident: 2191_CR19
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwj025
– volume: 9
  start-page: 106
  issue: 2
  year: 2013
  ident: 2191_CR34
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2012.263
– volume: 94
  start-page: 496
  issue: 446
  year: 1999
  ident: 2191_CR29
  publication-title: J Am Stat Assoc
  doi: 10.1080/01621459.1999.10474144
– volume: 98
  start-page: 1334
  issue: 18
  year: 2012
  ident: 2191_CR4
  publication-title: Heart.
  doi: 10.1136/heartjnl-2012-301682
– volume: 11
  start-page: e004476
  issue: 3
  year: 2018
  ident: 2191_CR16
  publication-title: Circ Hear Fail
  doi: 10.1161/circheartfailure.117.004476
– volume: 158
  start-page: 338
  issue: 5 Pt 1
  year: 2013
  ident: 2191_CR6
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-158-5-201303050-00007
– volume: 12
  start-page: e0184244
  issue: 9
  year: 2017
  ident: 2191_CR3
  publication-title: Plos One
  doi: 10.1371/journal.pone.0184244
– start-page: 4391
  volume-title: Practical recommendations for reporting Fine - Gray model analyses for competing risk data
  year: 2017
  ident: 2191_CR33
– volume: 81
  start-page: 1017
  issue: 8
  year: 1998
  ident: 2191_CR21
  publication-title: Am J Cardiol
  doi: 10.1016/s0002-9149(98)00082-4
– volume: 18
  start-page: 318
  issue: 4
  year: 2003
  ident: 2191_CR25
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.830
– volume: 33
  start-page: 1556
  issue: 12
  year: 2017
  ident: 2191_CR14
  publication-title: Can J Cardiol
  doi: 10.1016/j.cjca.2017.09.024
– volume: 60
  start-page: 1724
  issue: 9
  year: 2012
  ident: 2191_CR5
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2012.04097.x
– volume: 56
  start-page: 8035
  issue: 12
  year: 2019
  ident: 2191_CR13
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-019-01655-0
– volume-title: Package ‘cmprsk’: subdistribution analysis of competing risks
  year: 2019
  ident: 2191_CR32
– ident: 2191_CR31
– volume: 57
  start-page: 1945
  issue: 11
  year: 2001
  ident: 2191_CR11
  publication-title: Neurology.
  doi: 10.1212/WNL.57.11.1945
– volume: 121
  start-page: 410
  issue: 4
  year: 2018
  ident: 2191_CR7
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2017.11.003
– volume: 25
  start-page: 146
  issue: 3
  year: 2018
  ident: 2191_CR12
  publication-title: Neuroimmunomodulation.
  doi: 10.1159/000493142
– volume: 22
  start-page: 195
  issue: 2
  year: 1991
  ident: 2191_CR15
  publication-title: Stroke.
  doi: 10.1161/01.STR.22.2.195
– volume: 28
  start-page: 1
  issue: 1
  year: 2018
  ident: 2191_CR8
  publication-title: Neuropsychol Rev
  doi: 10.1007/s11065-017-9359-z
– volume: 140
  start-page: E1
  issue: 1
  year: 2000
  ident: 2191_CR20
  publication-title: Am Heart J
  doi: 10.1067/mhj.2000.106647
– ident: 2191_CR17
  doi: 10.1093/eurheartj/ehx365
– volume: 66
  start-page: i162
  issue: Suppl 1
  year: 2011
  ident: 2191_CR26
  publication-title: J Gerontol B Psychol Sci Soc Sci
  doi: 10.1093/geronb/gbr048
– volume-title: Health and Retirement Study Imputation of Cognitive Functioning Measures: 1992–2014
  year: 2017
  ident: 2191_CR28
SSID ssj0017826
Score 2.3382716
Snippet Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive...
We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive impairment (CI)...
Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent cognitive...
Abstract Background We sought to examine whether people with a diagnosis of cardiovascular disease (CVD) experienced a greater incidence of subsequent...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 274
SubjectTerms Age
Aged
Aging
Angina
Cardiac arrhythmia
Cardiovascular disease
Cardiovascular diseases
Chronic illnesses
Cognition
Cognition & reasoning
Cognition disorders
Cognitive ability
Complications and side effects
Congestive heart failure
Coronary artery disease
Death
Diagnosis
Gender
Geriatric cardiology
Geriatrics
Geriatrics/Gerontology
Health aspects
Heart failure
Hispanic people
Medicine
Medicine & Public Health
Memory
Myocardial infarction
Older people
Polls & surveys
Population
Psychological aspects
Rehabilitation
Research Article
Risk factors
Statistics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxUxEA5SivgirdetVSIIPujS3dw2-1iLxQctIgp9C7niEd1TzqXQf-9M9mK3or74sAf2ZLIkmUlmJpn5QsgL523iNqUy8CqWwsaqtEEoeAXt3jBnncyJwu-bszN9ft5-vHbVF8aE9fDA_cAdBR8clwlqKScQTKS1IYaYbCVZYj6n-YLVMzpTw_kB6D01pshodbSGVbhpSgxHgAdjfWZqKKP1_74mX1NKNwMmb5yaZmV0ukfuDlYkPe5bv09uxe4euf1hOCe_T76dzMJM6XAMQ20XqN_-yFd2XUaK--z5TlG6THQKJKKYOblY4bYhUFCwEGmfrJSrf4qbRb-nSDEG8eoB-XL69vPJu3K4VaH0qmo2JfgXUgRdJxa84jFxIVwFjqr0NUvSeo9J-1UAxZZc44SGn4ZF3nLX1kHBCvCQ7HTLLj4mlIloebDOViwIEWNrk2bB1cLXvpIyFaQeB9n4AXIcb774brLroZXpGWOAKSYzxlQFeTXVuegBN_5K_QZ5N1EiWHb-A0TIDCJk_iVCBXmJnDc4paF53g6ZCdBJBMcyx2jDIGaWLMjhjBKmop8Xj7JjhqVgbZhkWreaKyh-PhVjTQxv6-JyizQ1-L1ovxbkUS9qU5c4b8GOUqogzUwIZ32el3SLrxkoHIGOJH7z9Siuv5r15zE9-B9j-oTcYXm6iZKpQ7KzWW3jU7LrLzeL9epZnqw_AakzROc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: SpringerLINK Contemporary 1997-Present
  dbid: RSV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zi9UwFA46ivjivlRHiSD4oMU2W9PHcXDwQQcZF-YtZNUr2it3GfDfe066aMcF9KEXenNSmvRsyTnnCyEPnbeJ25TKwKtYChur0gah4Base8OcdTIXCr9sDg_18XH7eigKW4_Z7mNIMmvqLNZaPV2DJm2aElMK4MJ8nbPkHJg7jeJ49Ob9FDsAm6fG8pjf9puZoIzU_6s-_skgnU6WPBUxzYbo4PL_DeEKuTQ4nnSv55Sr5EzsrpELr4bQ-nXyaX-WmUqHyA21XaB--yWf8nUSKW7N52NI6TLRKfeIYrHlYoU7jUBBwamkfX1T7n4UN4t-G5Ji2uK3G-TdwfO3-y_K4SCG0quq2ZSwJJEi6Dqx4BWPiQvhKljbSl-zJK33WOdfBbCFyTVOaPhpWOQtd20dFCiNm2SnW3bxNqFMRMuDdbZiQYgYW5s0C64WvvaVlKkg9fhtjB9QyvGwjM8mr1a0Mv0kGphAkyfRVAV5PPX52mN0_JX6GX7yiRLxtfMfy9UHM4irCT44LhPwqnICIWxaG2KIyVaSJeZ1QR4hwxjUAvB63g7FDDBIxNMye-j2IMyWLMjujBKk18-bR5Yzg_ZYGyaZ1q3mCpofTM3YEzPiurjcIk0NS2V0eQtyq-fQaUict-B6KVWQZsa7szHPW7rFx4wtjthIEp_5ZOTgH6_15zm982_kd8lFloVAlEztkp3NahvvkfP-ZLNYr-5naf4OV9NHFg
  priority: 102
  providerName: Springer Nature
Title Cardiovascular disease and cumulative incidence of cognitive impairment in the Health and Retirement Study
URI https://link.springer.com/article/10.1186/s12877-021-02191-0
https://www.ncbi.nlm.nih.gov/pubmed/33902466
https://www.proquest.com/docview/2528898365
https://www.proquest.com/docview/2518990015
https://pubmed.ncbi.nlm.nih.gov/PMC8074515
https://doaj.org/article/dcdb35f2ba6b405999adedefa052f2c8
Volume 21
WOSCitedRecordID wos000645595000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1471-2318
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017826
  issn: 1471-2318
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Open Access Full Text
  customDbUrl:
  eissn: 1471-2318
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017826
  issn: 1471-2318
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-2318
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017826
  issn: 1471-2318
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1471-2318
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017826
  issn: 1471-2318
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1471-2318
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017826
  issn: 1471-2318
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1471-2318
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017826
  issn: 1471-2318
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1471-2318
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017826
  issn: 1471-2318
  databaseCode: RSV
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1rb9Mw0GIdQvvCeyMwKiMh8QGiJX4l-YS2aRNIrKrKQ-WT5fgBRZCOPibx7_E5bkaG2Bc-NJJru8r1znfneyL0vNbKUeVcamhmU6ZslirDhB966V6QWtU8JAq_K0ajcjqtxtHgtoxhlRueGBi1mWuwkR8QTsqyKqngr89_ptA1CryrsYXGFtqGSmVsgLaPTkbjSedH8PJPbFJlSnGw9Ny4KFIIS_AfiPnpiaNQtf9v3vyHcLoaOHnFexqE0umd_wXnLrod1VF82NLPPXTDNvfRrbPocH-Avh334lVx9Odg1Ris1z9C768Li8FgH5qT4rnDXUQShhTM2QLsj34F9qombrOewvaJXc1a4ySGYMZfD9HH05MPx2_S2J4h1SIrVqm_qHBmytwRowW1jjJWZ_7Gy3VOHFdaQ_Z_ZryEdHVRs9I_CmJpResqN8Kzkl00aOaNfYQwYVZRo2qVEcOYtZVyJTF1znSuM85dgvINlqSOtcuhhcZ3Ge4wpZAtZqXHqgyYlVmCXnZ7ztvKHdeuPgLkdyuh6nb4Yr74IuMhlkabmnLnKVjUDArbVMpYY53KOHFElwl6AaQjgTf419Mqpjh4IKHKljwEZQiKb_EE7fdW-jOt-9MbqpGRpyzlJckk6Fk3DTshTq6x8zWsyf0FGhThBO21tNqBRGnlFTIhElT0qLgHc3-mmX0NFcehYhKH33y1offL1_r3f_r4eiieoB0STiJLidhHg9VibZ-im_piNVsuhmirmBbhWQ7jqR4Gg4kfjd-ejT_70eT9p99uOVgX
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcCF9yNQwEggDiVq4thOckCoFKpW3a4QKtLejOMHLIJs2UdR_xS_kRkn2ZIieuuBw6608TjKZGe-GdvzIORZZbTPtPexzRIXc-2SWFsu4SdY95xVuhIhUXiQD4fFaFS-XyG_ulwYDKvsMDEAtZ0Y3CPfYIIVRVlkUrw-_BFj1yg8Xe1aaDRiseeOf8KSbfZq9y38v88Z2353sLUTt10FYiOTfB6Dfy24LVLPrJGZ8xnnVQILNWFS5oU2BpPWEwvA7qu84gV85cxlZVaVqZWgAXDfC-Qi4HiOIWT5aLnAS8Hayi4xp5AbM8D-PI8xCAI-GGHUM36hR8DfluAPU3g6TPPUWW0wgdvX_7eXd4Nca51tutlox02y4upb5PJ-G05wm3zd6kXj0va0iuraUrP4HjqbHTmKxxGh9SqdeLqMt6KYYDqe4u4qUFBwpGmT0xWmf3DzcbP1SjFU8_gO-XgunN4lq_WkdvcJZdzpzOpKJ8xy7lypfcFslXKTmkQIH5G0kwpl2srs2CDkmwortEKqRpIUSJEKkqSSiKwv5xw2dUnOpH6DwrakxJri4cJk-lm1EKWssVUmPOinrDiW7Sm1ddZ5nQjmmSki8gJFVSHyweMZ3SZwAJNYQ0xtoquHpcVERNZ6lIBYpj_cSalqEXOmTkQ0Ik-XwzgTowBrN1kgTVqA9wQebETuNbqxZCnLSnA3pYxI3tOaHs_9kXr8JdRTx3pQAu_5stOvk8f69zt9cDYXT8iVnYP9gRrsDvcekqssoACPmVwjq_Ppwj0il8zRfDybPg4YQsmn89a73yB4rBI
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Za9RAeNAqpS_erdGqIwg-aGgyVyaPtboo1qV40bdhTl3RbNnNFvz3zjfJxqYeID5kITvfhMzkO-e7EHpkrA5Uh5A7WvicaV_k2jERb6N0r4jRhqdE4cNqOpXHx_XRmSz-FO2-dkl2OQ1Qpalp905c6Ehcir1l5KpVlUN4QbwgduciusSgaRDY6-8-Dn6EKP_EOlXmt_NG4ihV7f-VN58RTucDJ895T5NQmlz9_-VcQ1d6hRTvdxh0HV3wzQ20-aZ3ud9EXw5GEau49-hg3ThsV99S969Tj-HIPrUnxfOAh5gkDEmYswWcQEYIHJVN3OU9pelvfTvrjicxhDN-v4U-TF68P3iZ9w0aciuKqs2jqcKZk2UgzgrqA2XMFNHm5bYkgWtrIf-_cFFGBlMZJuNPRTytqalLJyIz2UYbzbzxtxEmzGvqtNEFcYx5X-sgiTMls6UtOA8ZKtffSdm-ejk00fiqkhUjheo2UcUNVGkTVZGhJ8Ock652x1-hn8HnHyCh7nb6Y774pHoyVs46Q3mIOCwMg9I2tXbe-aALTgKxMkOPAXkUcIf4elb3SQ5xkVBnS-2DOgTlt3iGdkeQkarteHiNfqrnKktFOJGyllTE4YfDMMyESLnGz1cAU0YTGlThDO102DosidI6qmRCZKga4fFozeORZvY51RyHmkkcnvl0jc0_X-vPe3rn38AfoM2j5xN1-Gr6-i7aIokeWE7ELtpoFyt_D122p-1subifiPwH1U5S3g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiovascular+disease+and+cumulative+incidence+of+cognitive+impairment+in+the+Health+and+Retirement+Study&rft.jtitle=BMC+geriatrics&rft.au=Covello%2C+Allyson+L&rft.au=Horwitz%2C+Leora+I&rft.au=Singhal%2C+Shreya&rft.au=Blaum%2C+Caroline+S&rft.date=2021-04-26&rft.pub=Springer+Nature+B.V&rft.eissn=1471-2318&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12877-021-02191-0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2318&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2318&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2318&client=summon